Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

961
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
961

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trabeculectomy Remains Essential for Glaucoma Care.

Ophthalmology. Glaucoma·2026
Same author

Innovating global regulatory frameworks for generative AI in medical devices is an urgent priority.

NPJ digital medicine·2026
Same author

<i>Atf6</i> <sup>-/-</sup> mouse photoreceptors exhibit novel ciliary rootlet defect.

bioRxiv : the preprint server for biology·2026
Same author

Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports.

Case reports in pathology·2026
Same author

Primary hypertrophic osteoarthropathy presenting with ptosis and floppy eyelids: a review of ophthalmic manifestations, histopathology, and pathophysiology.

Orbit (Amsterdam, Netherlands)·2026
Same author

Proteomic profile of faricimab-associated occlusive retinal vasculitis.

Eye (London, England)·2025

相关实验视频

Updated: Jan 15, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K

与netarsudil相关的结膜组织病理变化0.02

Michelle T Sun1,2, Chaow Charoenkijkajorn3, Jonathan H Lin3

  • 1Byers Eye Institute, Stanford University, Stanford, CA, USA. michelle.sun@adelaide.edu.au.

Eye (London, England)
|October 9, 2025
PubMed
概括

在青光眼患者中,局部内塔苏迪尔0.02%的使用与明显更厚的结膜上皮和更高的结膜炎症概率有关. 这些变化可能会影响手术结果,需要进一步调查.

更多相关视频

Author Spotlight: Challenges in Developing Dry Eye Animal Models and Future Research Directions
04:06

Author Spotlight: Challenges in Developing Dry Eye Animal Models and Future Research Directions

Published on: February 9, 2024

2.8K
Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration
07:39

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

2.7K

相关实验视频

Last Updated: Jan 15, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.8K
Author Spotlight: Challenges in Developing Dry Eye Animal Models and Future Research Directions
04:06

Author Spotlight: Challenges in Developing Dry Eye Animal Models and Future Research Directions

Published on: February 9, 2024

2.8K
Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration
07:39

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

2.7K

科学领域:

  • 眼科医生 眼科 眼科
  • 组织病理学 组织病理学

背景情况:

  • 青光眼的管理通常涉及多种局部药物.
  • 尼塔苏迪尔是一种用于降低眼内压力 (IOP) 的Rho-酶抑制剂.

研究的目的:

  • 为了研究使用局部netarsudil0.02%的患者的结膜组织病理变化.

主要方法:

  • 结膜样本的观察性比较案例系列,来自绿眼瘤手术患者.
  • 由三个独立的病理学家进行的组织病理学分析和炎症评分.

主要成果:

  • 使用内塔苏迪尔的患者表现出明显更厚的结膜上皮 (90.1μm vs 43.2μm) 和更高上皮细胞厚度的趋势.
  • 所有接受了netarsudil治疗的样本都表现出炎症 (≥0.5分),而非netarsudil使用者的比例为64.7% (p=0.03).
  • 在分析之前停止服用内塔苏迪尔的患者中没有发现显著的组织病理差异.

结论:

  • 与其他青光眼药物治疗方案相比,暴露于netarsudil的结膜可能会出现炎症增加.
  • 这些组织病理学发现可能会对眼外科手术的结果产生影响.
  • 需要进一步的研究来将这些变化与临床结果相关联.